Related Experiment Videos
[New aspects in the treatment of breast cancer (author's transl)]
Abstract:
The specific treatment of primary breast carcinoma in the future may depend on viral genes in the development of antiviral substances, or a specific chemotherapeutic method. In this manner the turnover rate of the RNS virus is successfully inhibited (as the preceding communicated observations about the probably produced inhibition effect of rifampicin derivates of streptovarizin complexes). Prophylactically, by familiar breast cancer, breast feeding must be prohibited so that a supposed virus factor would not transfer with the milk. So far we hope that a supposed virus diagnosis of the primary tumor leads to decreased surgical interventions (tumorectomy, radical mastectomy), and technical as well as high energy postradiotherapy. This would not only give a smaller psychologic shock to the patient (small operation trauma) but would also decrease the complications (arm edema, movement restriction). This opinion now appears to effect international thinking after radical and subradical surgery have not given better results. For the late stage there is modern chemotherapy, combined with proper radiotherapy treatment of painful skeletal metastases, eventually also brain metastases which can now be successfully irradiated. Whether better late results are obtained by the early chemotherapy as well as the improvement of the immunity reaction quickly after sugical intervention (modified radical mastectomy) will be seen in the near future.
Insights
Future breast cancer treatment may involve targeting viral genes with antiviral substances or chemotherapy, potentially reducing surgery and radiotherapy. Prohibiting breastfeeding is advised to prevent virus transmission, aiming for less patient trauma and fewer complications.
Area of Science:
- Oncology
- Virology
- Pharmacology
Context:
- Primary breast carcinoma treatment is evolving beyond traditional surgery and radiotherapy.
- The potential role of viral factors in breast cancer development is under investigation.
- Current treatment paradigms are being re-evaluated based on outcomes and patient impact.
Purpose:
- To explore the potential of antiviral substances and novel chemotherapeutic methods for primary breast carcinoma.
- To investigate the inhibition of RNA virus turnover using streptovarizin complexes and rifampicin derivatives.
- To assess the impact of viral diagnosis on surgical and radiotherapeutic interventions for breast cancer.
Summary:
- The study discusses future therapeutic strategies for primary breast carcinoma, focusing on antiviral agents targeting viral genes and specific chemotherapeutic approaches.
- It highlights the successful inhibition of RNA virus turnover by streptovarizin complexes and rifampicin derivatives.
- Prophylactic measures include prohibiting breastfeeding to prevent potential virus transmission. The research anticipates reduced surgical and radiotherapeutic interventions, leading to decreased patient trauma and complications like lymphedema.
Impact:
- Potential for less invasive breast cancer treatments, reducing surgical trauma and post-operative complications.
- Suggests a paradigm shift in breast cancer management, integrating virology and chemotherapy.
- Aims to improve patient outcomes and quality of life through targeted therapies and reduced intervention intensity.